Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

6.59
+0.35005.61%
Post-market: 6.600.0100+0.15%19:59 EST
Volume:19.23M
Turnover:123.16M
Market Cap:2.65B
PE:-3.90
High:6.64
Open:6.20
Low:6.15
Close:6.24
Loading ...

Stock Track | Recursion Pharmaceuticals Soars 5.13% on Optimism Around Upcoming Clinical Milestones

Stock Track
·
08 Mar

4 Things You Need to Know if You Buy Recursion Pharmaceuticals Stock Today

Motley Fool
·
07 Mar

Down Over 40%, Is Recursion Pharmaceuticals a Buy on the Dip?

Motley Fool
·
06 Mar

News Flash: Analysts Just Made A Sizeable Upgrade To Their Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Forecasts

Simply Wall St.
·
05 Mar

AI Biotech Stocks Shined, With Ginkgo Up 8%, Recursion And Absci Up 4%, Crispr Up 3%

Tiger Newspress
·
05 Mar

Analysts Offer Insights on Healthcare Companies: Ramsay Health Care (OtherRMSYF) and Recursion Pharmaceuticals (RXRX)

TIPRANKS
·
05 Mar

Why Recursion Pharmaceuticals, Inc. (RXRX) Crashed on Monday

Insider Monkey
·
05 Mar

Recursion Pharmaceuticals Inc (RXRX) Q4 2024 Earnings Call Highlights: Strong Financial ...

GuruFocus.com
·
04 Mar

Recursion Pharmaceuticals (NasdaqGS:RXRX) Surges 6% Following US$500 Million Follow-On Equity Offering

Simply Wall St.
·
04 Mar

Stock Track | Recursion Pharmaceuticals Plunges 5.06% on Wider-Than-Expected Q4 Loss

Stock Track
·
03 Mar

Company News for Mar 3, 2025

Zacks
·
03 Mar

Recursion Pharmaceuticals Full Year 2024 Earnings: Misses Expectations

Simply Wall St.
·
01 Mar

Recursion Pharmaceuticals Reports Mixed 2024 Financial Results

TIPRANKS
·
01 Mar

Cathie Wood’s ARK Investment buys 653K shares of Recursion Pharmaceuticals today

TIPRANKS
·
01 Mar

Strong Buy Recommendation for Recursion Pharmaceuticals: Leading Techbio Innovator with Robust Financials and Strategic AI Integration

TIPRANKS
·
01 Mar

Recursion Pharmaceuticals (RXRX) Gets a Hold from TD Cowen

TIPRANKS
·
01 Mar